The results of our quantitative analysis of SMN2 gene copies clearly show that the disease phenotype is influenced by the number of copies of the SMN2 gene, consistent with previous studies indicating that type II and III patients have on average a larger number of SMN2 copies than type I SMA patients [50–53]. Here, SMN2 is linked to proximal spinal muscular atrophy.